Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessive pattern.
Scope of the Report:
This report studies the Krabbe Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Krabbe Disease Treatment market by product type and applications/end industries.
Although there is no known cure for Krabbe disease, bone marrow transplantation has been shown to benefit cases early in the course of the disease. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation. Cord blood transplants have been successful in stopping the disease as long as they are given before overt symptoms appear.
The global Krabbe Disease Treatment market is valued at xx million in 2017 and is expected to reach xx million by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Krabbe Disease Treatment.
Europe also play important roles in global market, with market size of xx million in 2017 and will be xx million in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GlaxoSmithKline
Johnson & Johnson
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anticonvulsants
Muscle Relaxants
HSCT
Others
Market Segment by Applications, can be divided into
Hospitals
ASCs
Table of Contents
1 Krabbe Disease Treatment Market Overview
1.1 Product Overview and Scope of Krabbe Disease Treatment
1.2 Classification of Krabbe Disease Treatment by Types
1.2.1 Global Krabbe Disease Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Krabbe Disease Treatment Revenue Market Share by Types in 2017
1.2.3 Anticonvulsants
1.2.4 Muscle Relaxants
1.2.5 HSCT
1.2.6 Others
1.3 Global Krabbe Disease Treatment Market by Application
1.3.1 Global Krabbe Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 ASCs
1.4 Global Krabbe Disease Treatment Market by Regions
1.4.1 Global Krabbe Disease Treatment Market Size (Million ) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Krabbe Disease Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Krabbe Disease Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Krabbe Disease Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Krabbe Disease Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Krabbe Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Krabbe Disease Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Krabbe Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Krabbe Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Krabbe Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Krabbe Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Krabbe Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Krabbe Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Krabbe Disease Treatment Market Competition, by Players
3.1 Global Krabbe Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Krabbe Disease Treatment Players Market Share
3.2.2 Top 10 Krabbe Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Krabbe Disease Treatment Market Size by Regions
4.1 Global Krabbe Disease Treatment Revenue and Market Share by Regions
4.2 North America Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
5 North America Krabbe Disease Treatment Revenue by Countries
5.1 North America Krabbe Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
6 Europe Krabbe Disease Treatment Revenue by Countries
6.1 Europe Krabbe Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Krabbe Disease Treatment Revenue by Countries
7.1 Asia-Pacific Krabbe Disease Treatment Revenue by Countries (2013-2018)
7.2 China Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
8 South America Krabbe Disease Treatment Revenue by Countries
8.1 South America Krabbe Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Krabbe Disease Treatment by Countries
9.1 Middle East and Africa Krabbe Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Krabbe Disease Treatment Revenue and Growth Rate (2013-2018)
10 Global Krabbe Disease Treatment Market Segment by Type
10.1 Global Krabbe Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Krabbe Disease Treatment Market Forecast by Type (2018-2023)
10.3 Anticonvulsants Revenue Growth Rate (2013-2023)
10.4 Muscle Relaxants Revenue Growth Rate (2013-2023)
10.5 HSCT Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Krabbe Disease Treatment Market Segment by Application
11.1 Global Krabbe Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Krabbe Disease Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 ASCs Revenue Growth (2013-2018)
12 Global Krabbe Disease Treatment Market Size Forecast (2018-2023)
12.1 Global Krabbe Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Krabbe Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Krabbe Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Krabbe Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Krabbe Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Krabbe Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Krabbe Disease Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Krabbe Disease Treatment
Krabbe Disease Treatment
×